Literature DB >> 1246991

The effect of thrombocytopenia on the determination of platelet aggregation.

P H Levine.   

Abstract

Platelet aggregation has been widely assumed to be unmeasurable in thrombocytopenic samples. Using a sensitive differential self differential self-calibrating aggregometer, and standard aggregating agents, aggregation was measured in serially diluted platelet-rich plasma. Aggregation induced by ADP or collagen was reproducible at platelet counts as low as 50,000 per cu. mm., and with epinephrine aggregation was reproducible at platelet counts as low as 75,000 per cu. mm.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1246991     DOI: 10.1093/ajcp/65.1.79

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  3 in total

1.  High platelet count in platelet-rich plasma reduces measured platelet inhibition by abciximab but not tirofiban nor eptifibatide glycoprotein IIb/IIIa receptor antagonists.

Authors:  D J Kereiakes; T M Broderick; E M Roth; D Whang; M Mueller; P Lacock; L C Anderson; W Howard; C Blanck; J Schneider; C A Abbottsmith
Journal:  J Thromb Thrombolysis       Date:  2000-02       Impact factor: 2.300

2.  Differential effects of citrate versus PPACK anticoagulation on measured platelet inhibition by abciximab, eptifibatide and tirofiban.

Authors:  D J Kereiakes; T Lorenz; J J Young; G Kukielka; M N Mueller; L Nanniazzi-Alaimo; D R Phillips
Journal:  J Thromb Thrombolysis       Date:  2001-10       Impact factor: 2.300

3.  Platelet aggregation in chronic idiopathic thrombocytopenic purpura.

Authors:  A D Heyns; J Fraser; F P Retief
Journal:  J Clin Pathol       Date:  1978-12       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.